Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 8,434 shares, an increase of 35.6% from the December 15th total of 6,218 shares. Based on an average daily trading volume, of 11,018 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the company’s stock are short sold. Currently, 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 11,018 shares, the days-to-cover ratio is presently 0.8 days.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Oxbridge Re in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $5.00.
Get Our Latest Stock Analysis on OXBR
Hedge Funds Weigh In On Oxbridge Re
Oxbridge Re Stock Up 0.0%
Shares of OXBR traded up $0.00 during mid-day trading on Friday, hitting $1.23. 12,812 shares of the company’s stock were exchanged, compared to its average volume of 8,534. Oxbridge Re has a twelve month low of $1.12 and a twelve month high of $5.81. The firm has a fifty day moving average of $1.31 and a two-hundred day moving average of $1.72. The stock has a market cap of $9.43 million, a price-to-earnings ratio of -3.61 and a beta of 2.14.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its earnings results on Thursday, November 6th. The insurance provider reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Oxbridge Re had a negative return on equity of 47.76% and a negative net margin of 109.74%.The business had revenue of $0.65 million for the quarter, compared to analyst estimates of $0.74 million.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
